Biotechnology Assets (STU:041) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:041 Biotechnology Assets SA STU:041
19 GF Score
Price €0.25
GF Value €0.32
! 3 Warning Signs
View Full Analysis

What is Biotechnology Assets Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Biotechnology Assets Quality Rank Related Terms

STU:041
19GF Score
Biotechnology Assets SA STU:041
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biotechnology Assets (STU:041) Overvalued in 2026?

Based on GuruFocus' analysis, Biotechnology Assets stock appears to be undervalued. The current stock price of €0.25 is trading 20.9% below its estimated GF Value™ of €0.32.

Key valuation signals for STU:041:

  • Quality Rank:
  • GF Value™: €0.32 vs. price of €0.25 (20.9% below fair value)
  • GF Score™: 19/100 with 3 warning signs

No single metric tells the full story. See the STU:041 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biotechnology Assets Business Description

Other Exchanges BST:Spain
Address Avenida del Desarrollo Tecnologico, No. 11, Scientific and Technological Park, Jerez de la Frontera, ESP, 11591
ADL Bionatur Solutions SA is a Spanish biopharmaceutical company focused on the research, development, and manufacture of biological products for the pharmaceutical and animal health sectors. It specializes in fermentation-based biotechnological processes and produces ingredients such as probiotics, feed additives, antigens for vaccines, and other biological compounds. Its customers include animal health and pharmaceutical companies, to which it supplies both therapeutic and non-therapeutic products, as well as contract manufacturing and development services. The company operates through segments covering animal health and human health, with production facilities in Spain and commercial activity across Europe and other international markets. Revenue is generated primarily from product sales and contract manufacturing agreements with tier-one and tier-two animal health firms. Its development pipeline includes vaccine antigens and biological candidates targeting niche and orphan diseases.
19GF Score

Get the complete analysis for STU:041

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.25
Price
€0.32
GF Value